Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 2Sarcoma 1Prostatic Neoplasms 1Primary Care 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Hematologic Neoplasms 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1

Interventions

Blood Specimen Collection 15Exercise 11Standard of Care 9Behavior Therapy 8Surveys and Questionnaires 7Palliative Care 7Carboplatin 7Methods 6Early Intervention, Educational 6Surgical Procedures, Operative 5Practice Guidelines as Topic 5Paclitaxel 5Interviews as Topic 5Educational Status 5Diet Therapy 5Specimen Handling 4Salpingectomy 4Hyperthermic Intraperitoneal Chemotherapy 4Genetic Testing 4Genetic Counseling 4Drug Therapy 4Counseling 4Yoga 3Psychiatric Rehabilitation 3Music Therapy 3Magnetic Resonance Spectroscopy 3Laparoscopy 3Diathermy 3Cytoreduction Surgical Procedures 3Cisplatin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Ovarian Neoplasms × Darbepoetin alfa × Clear all
NCT06184867 2026-03-06

CATALYST

Rutgers, The State University of New Jersey

Phase NA Completed
50 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡